Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
Stroke Trial Links
Government Sites
Independent Sites
News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback
Search for Trials
PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
Ozagrel
Xanbon OKY-046

Action
Inhibitor of thromboxane A2 synthetase; antiplatelet agent; intended to treat cerebral artery vasospasm

Status
Not available in US. Clinically available in Japan for use in acute non-embolic ischemic stroke and prevention of cerebral vasospasm after subarachnoid hemorrhage.

Trial(s)
  = Ongoing
  = Completed

OKY-046 in prevention of cerebral vasospasm

Web Links and Publications
Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasm and delayed cerebral ischemic symptoms after subarachnoid hemorrhage due to aneurysmal rupture: a randomized double-blind study.
Neurol Res 1989 Jun;11(2):79-88.

UID: 112

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2009 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, November 20, 2009